Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10997806rdf:typepubmed:Citationlld:pubmed
pubmed-article:10997806lifeskim:mentionsumls-concept:C0679729lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C1518578lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0079083lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0144576lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0376690lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C1319266lld:lifeskim
pubmed-article:10997806lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:10997806pubmed:issue7lld:pubmed
pubmed-article:10997806pubmed:dateCreated2000-12-26lld:pubmed
pubmed-article:10997806pubmed:abstractTextThe combination of paclitaxel and carboplatin has become a widely used regimen in NSCLC due to phase II reports of moderate toxicity, reasonable activity and easy outpatient administration. Purpose of our present prospective study was to evaluate the dose response relationship of paclitaxel.lld:pubmed
pubmed-article:10997806pubmed:languageenglld:pubmed
pubmed-article:10997806pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10997806pubmed:citationSubsetIMlld:pubmed
pubmed-article:10997806pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10997806pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10997806pubmed:statusMEDLINElld:pubmed
pubmed-article:10997806pubmed:monthJullld:pubmed
pubmed-article:10997806pubmed:issn0923-7534lld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:MylonakisNNlld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:PavlidisNNlld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:Papadimitriou...lld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:KosmidisPPlld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:FountzilasGGlld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:SkarlosDDlld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:DimopoulosMMlld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:Papaconstanti...lld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:SamantasEElld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:KalophonosCClld:pubmed
pubmed-article:10997806pubmed:authorpubmed-author:NikolaidisCClld:pubmed
pubmed-article:10997806pubmed:issnTypePrintlld:pubmed
pubmed-article:10997806pubmed:volume11lld:pubmed
pubmed-article:10997806pubmed:ownerNLMlld:pubmed
pubmed-article:10997806pubmed:authorsCompleteYlld:pubmed
pubmed-article:10997806pubmed:pagination799-805lld:pubmed
pubmed-article:10997806pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:meshHeadingpubmed-meshheading:10997806...lld:pubmed
pubmed-article:10997806pubmed:year2000lld:pubmed
pubmed-article:10997806pubmed:articleTitlePaclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).lld:pubmed
pubmed-article:10997806pubmed:affiliationHygeia Hospital, Athens, Greece. parkosmi@otenet.grlld:pubmed
pubmed-article:10997806pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10997806pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10997806pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10997806pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10997806lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10997806lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10997806lld:pubmed